These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 24316867)

  • 1. Effect of lovastatin on coxsackievirus B3 infection in human endothelial cells.
    Werner B; Dittmann S; Funke C; Überla K; Piper C; Niehaus K; Horstkotte D; Farr M
    Inflamm Res; 2014 Apr; 63(4):267-76. PubMed ID: 24316867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of coxsackievirus infection in cardiomyocytes by small dsRNA targeting its cognate coxsackievirus adenovirus receptor.
    Sharma M; Mishra B; Saikia UN; Bahl A; Ratho RK
    Indian J Med Res; 2017 Oct; 146(4):520-527. PubMed ID: 29434067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiviral effect of Bosentan and Valsartan during coxsackievirus B3 infection of human endothelial cells.
    Funke C; Farr M; Werner B; Dittmann S; Überla K; Piper C; Niehaus K; Horstkotte D
    J Gen Virol; 2010 Aug; 91(Pt 8):1959-1970. PubMed ID: 20392896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of coxsackievirus and adenovirus receptor (CAR)-Fc fusion protein in Pichia pastoris and characterization of its anti-coxsackievirus activity.
    Zhang K; Yu H; Xie W; Xu Z; Zhou S; Huang C; Sheng H; He X; Xiong J; Qian G
    J Biotechnol; 2013 Apr; 164(4):461-8. PubMed ID: 23376619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coxsackievirus B3 Activates Macrophages Independently of CAR-Mediated Viral Entry.
    Mohamud Y; Lin JC; Hwang SW; Bahreyni A; Wang ZC; Luo H
    Viruses; 2024 Sep; 16(9):. PubMed ID: 39339932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interspecies differences in virus uptake versus cardiac function of the coxsackievirus and adenovirus receptor.
    Freiberg F; Sauter M; Pinkert S; Govindarajan T; Kaldrack J; Thakkar M; Fechner H; Klingel K; Gotthardt M
    J Virol; 2014 Jul; 88(13):7345-56. PubMed ID: 24741103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Coxsackievirus and Adenovirus Receptor: Glycosylation and the Extracellular D2 Domain Are Not Required for Coxsackievirus B3 Infection.
    Pinkert S; Röger C; Kurreck J; Bergelson JM; Fechner H
    J Virol; 2016 Jun; 90(12):5601-5610. PubMed ID: 27030267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Soluble recombinant coxsackievirus and adenovirus receptor abrogates coxsackievirus b3-mediated pancreatitis and myocarditis in mice.
    Yanagawa B; Spiller OB; Proctor DG; Choy J; Luo H; Zhang HM; Suarez A; Yang D; McManus BM
    J Infect Dis; 2004 Apr; 189(8):1431-9. PubMed ID: 15073680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human astrocytic cells support persistent coxsackievirus B3 infection.
    Zhang X; Zheng Z; Shu B; Liu X; Zhang Z; Liu Y; Bai B; Hu Q; Mao P; Wang H
    J Virol; 2013 Nov; 87(22):12407-21. PubMed ID: 24027313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of coxsackievirus B3 replication in human umbilical vein endothelial cells.
    Kühnl A; Rien C; Spengler K; Kryeziu N; Sauerbrei A; Heller R; Henke A
    Med Microbiol Immunol; 2014 Aug; 203(4):217-29. PubMed ID: 24615265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of coxsackievirus-B3-infected BALB/c mice with the soluble coxsackie adenovirus receptor CAR4/7 aggravates cardiac injury.
    Dörner A; Grunert HP; Lindig V; Chandrasekharan K; Fechner H; Knowlton KU; Isik A; Pauschinger M; Zeichhardt H; Schultheiss HP
    J Mol Med (Berl); 2006 Oct; 84(10):842-51. PubMed ID: 16924471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soluble coxsackie- and adenovirus receptor (sCAR-Fc); a highly efficient compound against laboratory and clinical strains of coxsackie-B-virus.
    Pinkert S; Dieringer B; Diedrich S; Zeichhardt H; Kurreck J; Fechner H
    Antiviral Res; 2016 Dec; 136():1-8. PubMed ID: 27773751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heparan sulfates and coxsackievirus-adenovirus receptor: each one mediates coxsackievirus B3 PD infection.
    Zautner AE; Körner U; Henke A; Badorff C; Schmidtke M
    J Virol; 2003 Sep; 77(18):10071-7. PubMed ID: 12941917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of Histone Deacetylase Activity Aggravates Coxsackievirus B3-Induced Myocarditis by Promoting Viral Replication and Myocardial Apoptosis.
    Zhou L; He X; Gao B; Xiong S
    J Virol; 2015 Oct; 89(20):10512-23. PubMed ID: 26269170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coxsackievirus B3 Infection of Human iPSC Lines and Derived Primary Germ-Layer Cells Regarding Receptor Expression.
    Böhnke J; Pinkert S; Schmidt M; Binder H; Bilz NC; Jung M; Reibetanz U; Beling A; Rujescu D; Claus C
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33513663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endogenous low-level expression of the coxsackievirus and adenovirus receptor enables coxsackievirus B3 infection of RD cells.
    Carson SD; Kim KS; Pirruccello SJ; Tracy S; Chapman NM
    J Gen Virol; 2007 Nov; 88(Pt 11):3031-3038. PubMed ID: 17947527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of coxsackie B virus infection by soluble forms of its receptors: binding affinities, altered particle formation, and competition with cellular receptors.
    Goodfellow IG; Evans DJ; Blom AM; Kerrigan D; Miners JS; Morgan BP; Spiller OB
    J Virol; 2005 Sep; 79(18):12016-24. PubMed ID: 16140777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early Treatment of Coxsackievirus B3-Infected Animals With Soluble Coxsackievirus-Adenovirus Receptor Inhibits Development of Chronic Coxsackievirus B3 Cardiomyopathy.
    Pinkert S; Dieringer B; Klopfleisch R; Savvatis K; Van Linthout S; Pryshliak M; Tschöpe C; Klingel K; Kurreck J; Beling A; Fechner H
    Circ Heart Fail; 2019 Nov; 12(11):e005250. PubMed ID: 31718319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody-dependent enhancement of coxsackievirus B3 infection of primary CD19+ B lymphocytes.
    Jarasch-Althof N; Wiesener N; Schmidtke M; Wutzler P; Henke A
    Viral Immunol; 2010 Aug; 23(4):369-76. PubMed ID: 20712481
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Lee YG; Park JH; Jeon ES; Kim JH; Lim BK
    J Microbiol Biotechnol; 2016 Nov; 26(11):2012-2018. PubMed ID: 27558433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.